ALLYSIA BILLOW: Open Payments
NPI 1306292909 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 41 payments from 10 companies in 2025. Trend: 2023 $1,164 · 2024 $1,327 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $382 |
| ABBVIE INC. | 4 | $290 |
| AstraZeneca Pharmaceuticals LP | 4 | $154 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Lilly USA, LLC | 4 | $68 |
| Amgen Inc. | 3 | $56 |
| Exact Sciences Corporation | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| HEARTFLOW, INC. | 1 | $17 |
| Abbott Laboratories | 1 | $14 |
Products named: Ozempic, QULIPTA, UBRELVY, FARXIGA, Wegovy, TRELEGY ELLIPTA, MOUNJARO, The Cologuard Plus Collection Kit.
Industry payments across OH — which companies pay providers there.
